In its second acquisition of the past four weeks, Lodo Therapeutics Corp., acquired Hibiskus Biopharma Inc. plus exclusive worldwide rights from the University of California Riverside and Michigan ...
NEW YORK, Sept. 3, 2020 /PRNewswire/ -- Lodo Therapeutics Corp. (Lodo), a biotechnology company reinventing natural product drug discovery by applying its informatics-enabled technology platform to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results